
Tanja Dowe & Nils Bottler
Hybrid Care Models – An Exciting Opportunity to Transform Healthcare and Forge New Partnerships
Purely virtual care hit real-world barriers—fragmented regulation, complex reimbursement, and the need for human connection. Hybrid care resolves the tension by integrating digital speed with in-person depth, unifying journeys, data, and workflows so payers, providers, and patients all see measurable value.

Hybrid providers are poised to become “payvidors,” integrating insurance and care delivery in one seamless, outcome-oriented experience.
The pandemic mainstreamed telehealth, but simply moving services online didn’t guarantee adherence or outcomes. Hybrid care reframes the model: a continuous, patient-centric pathway that blends virtual follow-ups with in-person touchpoints, embeds scheduling and data capture into workflows, and rides existing reimbursement rails. Born-digital operations then make it easier to harness AI, track progress for value-based contracts, and scale models investors actually back.
When Virtual Meets Physical:
How Care Flows—and Business Models—Change
What you’ll learn
-
How hybrid care is defined—continuous, patient-centric delivery that augments face-to-face medicine with digital convenience
-
Why existing reimbursement pathways and embedded workflow tools make adoption easier than purely virtual models
-
What AI and measurement unlock in born-digital organizations—faster integration, continuous tracking, and value-based readiness
-
Where investor interest concentrates—stable metrics, payer partnerships, and realistic expansion plans over hype
-
Which direction the market is heading—toward payvidor models that combine insurance, care, and user-experience excellence

Tanja is a Managing Director at Angelini Ventures, investing in digital health and connected device companies in an early commercial stage. Prior to joining Angelini Ventures, Tanja was the CEO of Debiopharm Innovation Fund where she built a portfolio of digital health and data-driven R&D tech companies, realizing two early exits with Kaiku Health and Voluntis, and consolidated a legacy portfolio of diagnostics investments including the exit of GenePOC. Before her career in venture capital, Tanja was the Managing Partner of Innomedica Ltd, a strategy and transaction consulting boutique in life sciences, and a founder-CEO of a market research agency, BioSolutions INT. During her career, Tanja has worked with over 90 HealthTech companies globally, leading to broad experience in innovative product development, commercial strategies, and building winning teams.
About the Author
Tanja Dowe

Connect

Nils Bottler is a healthcare-focused Venture Capitalist at Angelini Ventures and a Venture Partner at Think.Health, investing in early-stage start-ups across digital health and life sciences for the past ten years. With a background as both investor and operator, he has led and scaled companies like Endodont (MedTech) and newsenselab (Digital Therapeutics), and drove regional growth at Avi Medical (Primary Care). Before his work in healthcare he worked in investment banking and corporate innovation in the digital media industry.
About the Author
Nils Bottler
Connect

